Correlation Between Karuna Therapeutics and Vaxcyte
Can any of the company-specific risk be diversified away by investing in both Karuna Therapeutics and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karuna Therapeutics and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karuna Therapeutics and Vaxcyte, you can compare the effects of market volatilities on Karuna Therapeutics and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karuna Therapeutics with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karuna Therapeutics and Vaxcyte.
Diversification Opportunities for Karuna Therapeutics and Vaxcyte
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Karuna and Vaxcyte is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Karuna Therapeutics and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and Karuna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karuna Therapeutics are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of Karuna Therapeutics i.e., Karuna Therapeutics and Vaxcyte go up and down completely randomly.
Pair Corralation between Karuna Therapeutics and Vaxcyte
If you would invest 3,788 in Vaxcyte on December 12, 2024 and sell it today you would earn a total of 3,197 from holding Vaxcyte or generate 84.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Karuna Therapeutics vs. Vaxcyte
Performance |
| Timeline |
| Karuna Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| Vaxcyte |
Karuna Therapeutics and Vaxcyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Karuna Therapeutics and Vaxcyte
The main advantage of trading using opposite Karuna Therapeutics and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karuna Therapeutics position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.| Karuna Therapeutics vs. Blueprint Medicines Corp | ||
| Karuna Therapeutics vs. Amylyx Pharmaceuticals | ||
| Karuna Therapeutics vs. Day One Biopharmaceuticals | ||
| Karuna Therapeutics vs. X4 Pharmaceuticals |
| Vaxcyte vs. Larimar Therapeutics | ||
| Vaxcyte vs. Syndax Pharmaceuticals | ||
| Vaxcyte vs. Merus BV | ||
| Vaxcyte vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges |